Pictured L to R: Dane Wittrup (Koch Institute), Tyler Jacks (Koch Institute), Anne Deconinck (Koch Institute), Christopher Arendt (Takeda), Jesus Gomez-Navarro (Takeda), Nicholas Ferenc (Takeda)
The Koch Institute is honored to announce that Takeda Pharmaceuticals has given a generous $1 million gift to support groundbreaking research in immuno-oncology at the KI. The gift, aimed to encourage several novel research approaches over the next two years, will allow investigators to advance their understanding of the relationship between the immune system and cancer, and accelerate the development of new immunotherapeutic technologies. Immuno-oncology, prioritized by Takeda as “arguably one of the most impactful recent breakthroughs in cancer research” has been one of the KI’s five core focus areas since its founding. Read more.